A review of pain experienced during topical photodynamic therapy-Our experience in Dundee

Photodiagnosis and Photodynamic Therapy

Volumn 8, Issue 1, 2011, Pages 53-57

  Attili, Sasi Kiran ^a   Dawe, Robert ^a   Ibbotson, Sally ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

5 Aminolaevulinic acid; Methyl aminolevulinate; Pain; Photodynamic therapy; Phototosensitiser

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FLUORESCENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAIN; PARAMETER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CANCER; SKIN INJURY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; COMORBIDITY; FEMALE; GREAT BRITAIN; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS;

EID: 79951580129     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2010.12.008     Document Type: Article

References (30)

1. Morton C.A., McKenna K.E., Rhodes L.E., British Association of Dermatologists Therapy Guidelines, Audit Subcommittee and the British Photodermatology Group Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008, 159(December (6)):1245-1266.
2. Peng Q., Warloe T., Moan J., et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995, 62(November (5)):906-913.
3. Grapengiesser S., Ericson M., Gudmundsson F., Larko O., Rosen A., Wennberg A.M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002, 27(September (6)):493-497.
4. Kasche A., Luderschmidt S., Ring J., Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006, 5(April (4)):353-356.
5. Clark C., Bryden A., Dawe R., Moseley H., Ferguson J., Ibbotson S.H. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003, 19(June (3)):134-141.
6. Ericson M.B., Sandberg C., Stenquist B., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004, 151(6):1204-1212.
7. Radakovic-Fijan S., Blecha-Thalhammer U., Kittler H., Honigsmann H., Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 2005, 53(November (5)):823-827.
8. Moloney F.J., Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007, 157(July (1)):87-91.
9. Wiegell S.R., Stender I.M., Na R., Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003, 139(September (9)):1173-1177.
10. Steinbauer J.M., Schreml S., Babilas P., et al. Topical photodynamic therapy with porphyrin precursors-assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009, 8(August (8)):1111-1116.
11. Wiegell S.R., Wulf H.C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 2006, 54(April (4)):647-651.
12. Kuijpers D.I., Thissen M.R., Thissen C.A., Neumann M.H. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006, 5(July-August (7)):642-645.
13. Arits A.H., van de Weert M.M., Nelemans P.J., Kelleners-Smeets N.W. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010, 26(April).
14. Gholam P., Denk K., Sehr T., Enk A., Hartmann M. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010, 63(August (2)):213-218.
15. Schleier P., Berndt A., Kolossa S., Zenk W., Hyckel P., Schultze-Mosgau S. Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma. Photodiagn Photodynam Ther 2007, 4(3):197-201. 9.
16. Mikolajewska P., Iani V., Juzeniene A., Moan J. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema. Br J Dermatol 2009, 161(November (5)):1173-1179.
17. Wiegell S.R., Skiveren J., Philipsen P.A., Wulf H.C. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008, 158(April (4)):727-733.
18. Sandberg C., Stenquist B., Rosdahl I., et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006, 86(5):404-408.
19. Attili S.K., Lesar A., McNeill A., et al. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol 2009, 161(July (1)):170-173.
20. Wiegell S.R., Haedersdal M., Philipsen P.A., Eriksen P., Enk C.D., Wulf H.C. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008, 158(April (4)):740-746.
21. Virgili A., Osti F., Maranini C., Corazza M. Photodynamic therapy: parameters predictive of pain. Br J Dermatol 2010, 162(February (2)):460-461.
22. Lindeburg K.E., Brogaard H.M., Jemec G.B. Pain and photodynamic therapy. Dermatology 2007, 215(3):206-208.
23. Cottrell W.J., Paquette A.D., Keymel K.R., Foster T.H., Oseroff A.R. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008, 14(July (14)):4475-4483.
24. Fritsch C., Stege H., Saalmann G., Goerz G., Ruzicka T., Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 1997, 13(October-December (5-6)):181-185.
25. Morton C.A., Whitehurst C., Moore J.V., MacKie R.M. Comparison of red and green light in the treatment of bowen's disease by photodynamic therapy. Br J Dermatol 2000, 143(4):767-772.
26. Babilas P., Travnik R., Werner A., Landthaler M., Szeimies R.M. Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges 2008, 6(January (1)):25-32.
27. Wiegell S.R., Haedersdal M., Eriksen P., Wulf H.C. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009, 160(June (6)):1308-1314.
28. Langmack K., Mehta R., Twyman P., Norris P. Topical photodynamic therapy at low fluence rates-theory and practice. J Photochem Photobiol B 2001, 60(April (1)):37-43.
29. Moseley H., Allen J.W., Ibbotson S., et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol 2006, 154(April (4)):747-750.
30. Babilas P., Knobler R., Hummel S., et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 2007, 157(July (1)):111-117.